However, in mice treated with insulin for 4 weeks immediately after establishment of diabetes, or treated with glibenclamide following 4 weeks of hyperglycaemia, the number of ins+/glu+ cells was not significantly different from control animals (Fig. 5b). The gene discussed is INS; the disease is diabetes mellitus.